ArticleJournal of clinical medicine2022

Switching from Adalimumab Originator to Biosimilar: Clinical Experience in Patients with Hidradenitis Suppurativa.

Trinidad Montero-Vilchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.